Immune tolerance induction using Fc-fusion-protein recombinant factor IX in severe haemophilia B

Haemophilia. 2021 Nov;27(6):e776-e779. doi: 10.1111/hae.14424. Epub 2021 Oct 2.
No abstract available

Publication types

  • Letter

MeSH terms

  • Factor IX
  • Factor VIII
  • Hemophilia A* / drug therapy
  • Hemophilia B* / drug therapy
  • Humans
  • Immune Tolerance
  • Recombinant Fusion Proteins

Substances

  • Recombinant Fusion Proteins
  • Factor VIII
  • Factor IX